Relevant bibliographies by topics / Crohn's Diseases (CD)Bloating

Contents

  1. Journal articles
  2. Book chapters

Academic literature on the topic 'Crohn's Diseases (CD)Bloating'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Crohn's Diseases (CD)Bloating.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Crohn's Diseases (CD)Bloating"

1

Priyanka, Bhandari* Rahul Chauhan Sachin Sajwan. "Botanical Remedies for Managing Inflammatory Bowel Diseases." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 3168–81. https://doi.org/10.5281/zenodo.15462569.

Full text
Abstract:
Millions of people worldwide suffer from inflammatory bowel disease (IBD), a chronic inflammatory gastrointestinal disorder that includes Crohn's disease and ulcerative colitis. Although the exact cause is unknown, a complex interaction of immunological, environmental, and genetic variables is believed to be responsible. The incidence of IBD has increased over the past century, especially in industrialized countries, most likely as a result of environmental factors such as food, antibiotic usage, and urbanization that cause imbalances in the gut microbiota. Stress and smoking are also recogniz
APA, Harvard, Vancouver, ISO, and other styles
2

Starz, Eliza, Karolina Wzorek, Marcin Folwarski, et al. "The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn’s Disease." Nutrients 13, no. 7 (2021): 2125. http://dx.doi.org/10.3390/nu13072125.

Full text
Abstract:
Gastrointestinal symptoms in Crohn’s disease (CD) are common and affect the quality of life of patients; consequently, a growing number of studies have been published on diet interventions in this group. The role of the gut microbiota in the pathogenesis and the progression of inflammatory bowel diseases (IBD), including CD, has been widely discussed. Mainly, a decreased abundance of Firmicutes, species of the Bifidobacterium genus, and the Faecalibacterium prausnitzii species as well as a reduced general diversity have been described. In this review article, we summarize available data on the
APA, Harvard, Vancouver, ISO, and other styles
3

Kulygin, Yu A., and M. F. Osipenko. "Excessive bacterial growth syndrome in small intestine burdens the clinical picture of inflammatory bowel diseases." Experimental and Clinical Gastroenterology, no. 4 (July 26, 2023): 49–54. http://dx.doi.org/10.31146/1682-8658-ecg-212-4-49-54.

Full text
Abstract:
Research objective: to study the frequency of small intestinal bacterial overgrowth (SIBO) and factors associated with it in patients with inflammatory bowel diseases (IBD). Materials and methods of the study: 152 patients with IBD (Crohn’s disease and ulcerative colitis) a hydrogen breathing test (HBT) with lactulose, performed by the “Gastro+” monitor using lactulose. In all patients, the characteristics of the course of IBD were evaluated, including 60 parameters: the time of diagnosis of IBD, the existing symptoms assessed by a visually analog scale (VAS), extra-intestinal manifestations,
APA, Harvard, Vancouver, ISO, and other styles
4

Vinni, E., K. Karaivazoglou, T. Lourida, et al. "P194 Alexithymia traits are associated with symptom severity and disease activity in IBD patients." Journal of Crohn's and Colitis 15, Supplement_1 (2021): S260. http://dx.doi.org/10.1093/ecco-jcc/jjab076.320.

Full text
Abstract:
Abstract Background Alexithymic traits are quite prevalent in patients with inflammatory bowel diseases (IBD) and have been linked with a heightened psychological burden including anxiety, depression, somatization and obsessive-compulsive symptoms. However, there are limited data regarding the association of alexithymia with gastrointestinal symptom severity and disease activity. Methods The current study was conducted at the Division of Gastroenterology of the University Hospital of Patras, in Greece with the collaboration of the Department of Psychiatry. Adult IBD outpatients and healthy con
APA, Harvard, Vancouver, ISO, and other styles
5

Saunders, B., K. Lesack, R. Rosentreter, et al. "P771 Comparing obstructive symptoms and dietary restrictions with Crohn's disease stricture severity." Journal of Crohn's and Colitis 18, Supplement_1 (2024): i1439. http://dx.doi.org/10.1093/ecco-jcc/jjad212.0901.

Full text
Abstract:
Abstract Background Stricturing Crohn’s Disease (CD) is characterized by bowel narrowing often leading to obstruction. Obstructive symptoms (OS) have been evaluated in patients with CD strictures using OS scores (STRIDENT). Clinical observations suggest that OS are generally associated with end-stage strictures requiring dietary restrictions and surgery. Evaluating the prevalence of symptoms in strictures is important as regulatory agencies require symptom response to therapies in trials. Intestinal ultrasound (IUS) accurately assesses CD strictures. IUS criteria for ileal strictures includes:
APA, Harvard, Vancouver, ISO, and other styles
6

Boscarelli, Alessandro, and Matteo Bramuzzo. "Pediatric stricturing Crohn's disease." World Journal of Gastroenterology 30, no. 12 (2024): 1651–54. http://dx.doi.org/10.3748/wjg.v30.i12.1651.

Full text
Abstract:
Crohn’s disease (CD) is a chronic inflammatory disease of the digestive tract. The incidence of pediatric CD is increasing and is currently 2.5–11.4 per 100000 world-wide. Notably, approximately 25% of children with CD develop stricturing CD (SCD) that requires intervention. Symptomatic stricturing diseases refractory to pharmacological management frequently require non-pharmacological interventions. Non-pharmacological therapeutic strategies include endoscopic balloon dilatation, stricturoplasty, and surgical resection of the strictured segment. However, strictures tend to recur postoperative
APA, Harvard, Vancouver, ISO, and other styles
7

Khalaf, Asseel, Caroline L. Hoad, Alex Menys, et al. "Gastrointestinal peptides and small-bowel hypomotility are possible causes for fasting and postprandial symptoms in active Crohn's disease." American Journal of Clinical Nutrition 111, no. 1 (2019): 131–40. http://dx.doi.org/10.1093/ajcn/nqz240.

Full text
Abstract:
ABSTRACT Background Crohn's disease (CD) patients suffer postprandial aversive symptoms, which can lead to anorexia and malnutrition. Changes in the regulation of gut hormones and gut dysmotility are believed to play a role. Objectives This study aimed to investigate small-bowel motility and gut peptide responses to a standard test meal in CD by using MRI. Methods We studied 15 CD patients with active disease (age 36 ± 3 y; BMI 26 ± 1 kg/m 2) and 20 healthy volunteers (HVs; age 31 ± 3 years; BMI 24 ± 1 kg/m 2). They underwent baseline and postprandial MRI scans, symptom questionnaires, and blo
APA, Harvard, Vancouver, ISO, and other styles
8

Evers, Charles D., Aishwarya Ravindran, Frida Rosenblum, and Frederick Weber. "A Pelvic Mass in a Young Patient With Crohn's Disease." ACG Case Reports Journal 12, no. 3 (2025): e01627. https://doi.org/10.14309/crj.0000000000001627.

Full text
Abstract:
ABSTRACT Castleman disease (CD) is a rare group of lymphoproliferative disorders subdivided based on clinical features. Although not fully understood, the pathogenesis of both CD and Crohn's disease involves a combination of immune dysregulation and infectious and environmental factors. Interleukin-6, a proinflammatory cytokine, is associated with both diseases and can serve as a common therapeutic target in CD. We report a rare case of coexisting unicentric Castleman disease in a young patient with Crohn's disease.
APA, Harvard, Vancouver, ISO, and other styles
9

Herfarth, Hans H. "Methotrexate for Inflammatory Bowel Diseases - New Developments." Digestive Diseases 34, no. 1-2 (2016): 140–46. http://dx.doi.org/10.1159/000443129.

Full text
Abstract:
Methotrexate (MTX) is an established therapy for patients with steroid-dependent Crohn's disease (CD). MTX is also frequently used in combination with anti-TNF agents to suppress anti-drug antibody formation. It has been suggested in the past that MTX lacks any clinical effectiveness in patients with ulcerative colitis (UC); however, newer data at least partially contradict this assumption. The following review will discuss recent data for the use of MTX in CD, UC and in combination with anti-TNF agents.
APA, Harvard, Vancouver, ISO, and other styles
10

ZHARGALOVA, G. M., and P. V. SELIVERSTOV. "DIAGNOSTIC IMAGING IN CROHN'S DISEASE." AVICENNA BULLETIN 27, no. 2 (2025): 441–52. https://doi.org/10.25005/2074-0581-2025-27-2-441-452.

Full text
Abstract:
Crohn's disease (CD) is an inflammatory bowel disease with an unknown etiology, and many authors suggest that its prevalence is steadily increasing worldwide. Among the various diagnostic methods available, ileocolonoscopy with biopsy is considered the "gold standard" for detecting intestinal diseases. However, since CD can affect any part of the gastrointestinal tract, this method has limitations. It cannot examine the proximal parts of the small intestine or evaluate all layers of the intestinal wall. Furthermore, this invasive procedure is often poorly tolerated by patients, making it less
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Crohn's Diseases (CD)Bloating"

1

Ajabnoor, Sarah, and Hebah Khayat. "Inflammatory Bowel Diseases (Crohn's Disease)." In Cases on Medical Nutrition Therapy for Gastrointestinal Disorders. IGI Global, 2021. http://dx.doi.org/10.4018/978-1-7998-3802-9.ch007.

Full text
Abstract:
The case study presented in this chapter is related to Crohn's disease (CD). CD is a type of inflammatory bowel diseases (IBD) affecting both small and large bowels. Several factors are involved in the aetiopathogenesis of CD. Individuals diagnosed with CD will typically experience periods of relapse and remission. Therefore, the main aim of medical therapy in CD is to induce and maintain remission. The case presented in this chapter will demonstrate the role of medical nutrition therapy in a recently diagnosed patient with CD who was admitted with abdominal pain for 6 weeks and acute flare fo
APA, Harvard, Vancouver, ISO, and other styles
2

Grangeiro, Herick Parente, Livya Maria Vasconcelos Lima Sousa, Raissa Linhares Ribeiro de Menezes, Beatriz Silva de Sousa, Isac Tibúrcio de Araújo Silva, and Jordânia Marques de Oliveira Freire. "ORAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASES: THE ROLE OF ORAL HEALTH IN DIAGNOSIS AND CLINICAL MONITORING." In Scientific Interconnections: The Multidisciplinary Approach. Seven Editora, 2025. https://doi.org/10.56238/sevened2025.011-059.

Full text
Abstract:
The digestive system is responsible for the ingestion, digestion and absorption of nutrients, as well as the elimination of unabsorbed substances. Pathological conditions such as gastrointestinal infections, inflammatory bowel diseases (IBD) and neoplasms affect its function, impacting quality of life. Celiac disease (CD) is an autoimmune disorder triggered by gluten, whose oral manifestations, such as enamel defects and ulcers, are important for early diagnosis. Crohn's disease (CD) and ulcerative colitis (UC) also present oral complications such as stomatitis and periodontitis, which help in
APA, Harvard, Vancouver, ISO, and other styles
3

Gürünlü, Betül. "Beta Glucan in Treatment of Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Diseases (IBD): Ulcerative Colitis (UC) and Crohn's Disease (CD)." In Medical Applications of Beta-Glucan. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815039238122010011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Garg, Mr Satyendra. "Gastrointestinal (GI) System-I." In Edited Book of Pathophysiology. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/nbennurebch14.

Full text
Abstract:
The gastrointestinal system is responsible for digestion, nutrient absorption, and waste elimination, but it can be affected by various disorders, including peptic ulcers, inflammatory bowel diseases (IBD), and jaundice. Peptic ulcers are open sores that develop on the inner lining of the stomach and the upper part of the small intestine, primarily caused by Helicobacter pylori infection and the prolonged use of NSAIDs. The pathophysiology involves an imbalance between aggressive factors like acid and pepsin and the defensive mechanisms of the gastric mucosa. Epidemiologically, peptic ulcers a
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Crohn's Diseases (CD)Bloating' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography